Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L‐type Ca2+ current in rat ventricular myocytes
- 1 May 1999
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 127 (1) , 65-74
- https://doi.org/10.1038/sj.bjp.0702506
Abstract
The effects of several phosphodiesterase (PDE) inhibitors on the L-type Ca current (I(Ca)) and intracellular cyclic AMP concentration ([cAMP]i) were examined in isolated rat ventricular myocytes. The presence of mRNA transcripts encoding for the different cardiac PDE subtypes was confirmed by RT-PCR. IBMX (100 microM), a broad-spectrum PDE inhibitor, increased basal I(Ca) by 120% and [cAMP]i by 70%, similarly to a saturating concentration of the beta-adrenoceptor agonist isoprenaline (1 microM). However, MIMX (1 microM), a PDE1 inhibitor, EHNA (10 microM), a PDE2 inhibitor, cilostamide (0.1 microM), a PDE3 inhibitor, or Ro20-1724 (0.1 microM), a PDE4 inhibitor, had no effect on basal I(Ca) and little stimulatory effects on [cAMP]i (20-30%). Each selective PDE inhibitor was then tested in the presence of another inhibitor to examine whether a concomitant inhibition of two PDE subtypes had any effect on I(Ca) or [cAMP]i. While all combinations tested significantly increased [cAMP]i (40-50%), only cilostamide (0.1 microM)+ Ro20-1724 (0.1 microM) produced a significant stimulation of I(Ca) (50%). Addition of EHNA (10 microM) to this mix increased I(Ca) to 110% and [cAMP]i to 70% above basal, i.e. to similar levels as obtained with IBMX (100 microM) or isoprenaline (1 microM). When tested on top of a sub-maximal concentration of isoprenaline (1 nM), which increased I(Ca) by (approximately 40% and had negligible effect on [cAMP]i, each selective PDE inhibitor induced a clear stimulation of [cAMP]i and an additional increase in I(Ca). Maximal effects on I(Ca) were approximately 8% for MIMX (3 microM), approximately 20% for EHNA (1-3 microM), approximately 30% for cilostamide (0.3-1 microM) and approximately 50% for Ro20-1724 (0.1 microM). Our results demonstrate that PDE1-4 subtypes regulate I(Ca) in rat ventricular myocytes. While PDE3 and PDE4 are the dominant PDE subtypes involved in the regulation of basal I(Ca), all four PDE subtypes determine the response of I(Ca) to a stimulus activating cyclic AMP production, with the rank order of potency PDE4>PDE3>PDE2>PDE1.Keywords
This publication has 40 references indexed in Scilit:
- Altered Expression of PDE1 and PDE4 Cyclic Nucleotide Phosphodiesterase Isoforms in 7-oxo-prostacyclin-preconditioned Rat HeartJournal of Molecular and Cellular Cardiology, 1997
- Contribution of phosphodiesterase isozymes to the regulation of the L-type calcium current in human cardiac myocytesBritish Journal of Pharmacology, 1997
- Nitric oxide regulates the calcium current in isolated human atrial myocytes.Journal of Clinical Investigation, 1995
- Expression and regulation of human and rat phosphodiesterase type IV isogenesFEBS Letters, 1994
- Inhibition of the Different Phosphodiesterase Isoforms of Rat Heart Cytosol by Free Fatty AcidsJournal of Cardiovascular Pharmacology, 1993
- Cyclic AMP metabolism in intact rat ventricular cardiac myocytes: Interaction of carbachol with isoproterenol and 3-isobutyl-1-methylxanthineMolecular and Cellular Biochemistry, 1993
- Cyclic AMP phosphodiesterases and Ca2+ current regulation in cardiac cellsLife Sciences, 1991
- Involvement of Rolipram-Sensitive Cyclic AMP Phosphodiesterase in the Regulation of Cardiac ContractionJournal of Cardiovascular Pharmacology, 1990
- Species-dependent differences in the properties of particulate cyclic nucleotide phosphodiesterase from rat and rabbit ventricular myocardiumJournal of Pharmacy and Pharmacology, 1990
- Subclasses of cyclic AMP phosphodiesterase in cardiac muscleJournal of Molecular and Cellular Cardiology, 1987